FDA Inspection
Mitchell Horwitz, M.D.Mitchell Horwitz, M.D. – FDA Inspection, Aug 19, 2022
Record Details
This FDA Inspection record concerns Mitchell Horwitz, M.D., with an inspection on August 19, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Mitchell Horwitz, M.D.
- Inspection Date
- August 19, 2022
- Product Type
- Biologics
View Company Profile
ID · 9c6ae860-50a6-44e0-b0f2-ecab949fd205
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1177854
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mitchell Horwitz, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2026 | NAI | Bioresearch Monitoring |
Other documents for Mitchell Horwitz, M.D.
- FDA Inspection 1309210 - 2026-03-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.